Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate;Apnées tardives du prématuré : facteurs de risque, traitement ambulatoire par citrate de caféine

Archives de Pediatrie

Volumn 13, Issue 10, 2006, Pages 1299-1304

  Ducrocq, S ^a   Biran Mucignat, V ^a   Boelle, P Y ^b   Lebas, F ^a   Baudon, J J ^a   Gold, F ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST   (France)

Author keywords

Apnea; Caffeine; drug therapy; Infant; premature; therapeutic use

Indexed keywords

CAFFEINE CITRATE;

AIRWAY PRESSURE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPOTENSION; LIFE CYCLE; MALE; MULTIPARA; NEWBORN; NEWBORN APNEA; OUTPATIENT CARE; PREMATURITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AMBULATORY CARE; APNEA; BIRTH WEIGHT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRATES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOTENSION; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY, MULTIPLE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33748970627     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.06.016     Document Type: Article

References (16)

1. Henderson-Smart D.J. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust. Paediatr. J. 17 (1981) 273-276
2. Barrington K.J., Finer N., and Li D. Predischarge respiratory recordings in very low birth weight newborn infants. J. Pediatr. 129 (1996) 934-940
3. Darnall R.A., Kattwinkel J., Nattie C., et al. Margin of safety for discharge after apnea in preterm infants. Pediatrics 100 (1997) 795-801
4. Tauman R., and Sivan Y. Duration of home monitoring for infants discharged with apnea of prematurity. Biol. Neonate 78 (2000) 168-173
5. Eichenwald E.C., Aina A., and Stark A.R. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 100 (1997) 354-359
6. Rivkees S.A., Zhao Z., Porter G., et al. Influences of adenosine on the fetus and newborn. Mol. Genet. Metab. 74 (2001) 160-171
7. Bauer J., Maier K., Linderkamp O., et al. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 107 (2001) 660-663
8. Schmidt B., Roberts R.S., Davis P., et al. Caffeine therapy for apnea of prematurity. N. Engl. J. Med. 354 (2006) 2112-2121
9. Tamim H., Khogali M., Beydoun H., et al. Consanguinity and apnea of prematurity. Am. J. Epidemiol. 158 (2003) 942-946
10. Perfect-Sychowski S., Dodd E., Thomas P., et al. Home apnea monitor use in preterm infants discharged from newborn intensive care units. J. Pediatr. 139 (2001) 245-248
11. Donohue P.K., Baker S.F., and Allen S.C. Duration of apnea and bradycardia in VLBW infants. Pediatrics 100 (1997) 496-497 (abstract)
12. Barrington K.J., Tan K., and Rich W. Apnea at discharge and gastro-esophageal reflux in the preterm infant. J. Perinatol. 22 (2002) 8-11
13. Kohelet D., Boaz M., Serour F., et al. Esophageal pH study and symptomatology of gastroesophageal reflux in newborn infants. Am. J. Perinatol. 21 (2004) 85-91
14. Rosen C.L., Glaze D.G., and Frost Jr. J.D. Home monitor follow-up of persistent apnea and bradycardia in preterm infants. Am. J. Dis. Child. 140 (1986) 547-550
15. Di Fiore J.M., Arko M.K., Miller M.J., et al. Cardiorespiratory events in preterm infants referred for apnea monitoring studies. Pediatrics 108 (2001) 1304-1308
16. Barrington K., and Finer N. The natural history of the appearance of apnea of prematurity. Pediatr. Res. 29 (1991) 372-375